Lazard Asset Management LLC Sage Therapeutics, Inc. Transaction History

Lazard Asset Management LLC

$68.3 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.58 - $17.9 $18,663 - $31,575	1,764 Added 25.85%	8,589 $93,000
Q1 2024 May 14, 2024	BUY	$18.62 - $26.95 $127,081 - $183,933	6,825 New	6,825 $127,000
Q4 2021 Feb 09, 2022	SELL	$37.06 - $47.11 $1.01 Million - $1.29 Million	-27,292 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $1.1 Million - $1.57 Million	27,292 New	27,292 $1.21 Million
Q2 2021 Aug 12, 2021	SELL	$54.88 - $79.29 $47,800 - $69,061	-871 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$70.65 - $96.76 $61,536 - $84,277	871 New	871 $65,000
Q4 2020 Feb 11, 2021	SELL	$58.41 - $89.06 $96,843 - $147,661	-1,658 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$41.13 - $62.45 $267,057 - $405,487	-6,493 Reduced 79.66%	1,658 $101,000
Q2 2020 Aug 13, 2020	BUY	$25.95 - $43.15 $173,890 - $289,148	6,701 Added 462.14%	8,151 $338,000
Q1 2020 May 14, 2020	BUY	$26.15 - $77.24 $37,917 - $111,997	1,450 New	1,450 $41,000
Q3 2019 Nov 14, 2019	SELL	$140.29 - $189.96 $757,566 - $1.03 Million	-5,400 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$138.11 - $169.04 $915,531 - $1.12 Million	-6,629 Reduced 55.11%	5,400 $762,000
Q2 2018 Aug 13, 2018	BUY	$140.36 - $175.76 $930,446 - $1.17 Million	6,629 Added 122.76%	12,029 $1.88 Million
Q1 2018 May 14, 2018	SELL	$152.15 - $192.33 $554,586 - $701,042	-3,645 Reduced 40.3%	5,400 $869,000
Q4 2017 Feb 13, 2018	SELL	$60.72 - $167.34 $416,235 - $1.15 Million	-6,855 Reduced 43.11%	9,045 $1.49 Million
Q3 2017 Nov 13, 2017	SELL	$61.4 - $88.52 $589,440 - $849,792	-9,600 Reduced 37.65%	15,900 $990,000
Q2 2017 Aug 19, 2019	SELL	N/A	-900 Reduced 3.41%	25,500 $2.03 Million
Q1 2017 Aug 13, 2019	SELL	N/A	-30,900 Reduced 53.93%	26,400 $1.88 Million
Q4 2016 Jul 30, 2019	SELL	N/A	-24,300 Reduced 29.78%	57,300 $2.93 Million
Q3 2016 Aug 07, 2019	BUY	N/A	24,300 Added 42.41%	81,600 $3.76 Million
Q4 2015 Jul 24, 2019	SELL	N/A	-5,125 Reduced 8.21%	57,300 $3.34 Million
Q3 2015 Jul 15, 2019	SELL	N/A	-1,275 Reduced 2.0%	62,425 $2.64 Million
Q2 2015 Jul 08, 2019	BUY	N/A	63,700	63,700 $4.65 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account